Enbrel Schizophrenia Symptoms Reviewed by Health Canada

In response to concerns raised by a recent medical journal report, Canadian health officials indicate that they have conducted a safety review to evaluate the potential side effects of Enbrel and determine whether the anti-inflammation drug may increase the risk of users experiencing schizophrenia.

In a statement released late last month, Health Canada states that it could find no evidence of a link between Enbrel and schizophrenia symptoms based on available data. However, the agency will continue to monitor adverse event reports and medical literature on the issue.

Enbrel (etanercept) is a Tumor Necrosis Factor (TNF) Blocker distributed sold by Amgen which was introduced in 1998 to treat various auto immune disorders, such as Crohn’s disease, rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and juvenile idopathic arthritis (previously known as juvenile rheumatoid arthritis). It is administered as an injection.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The safety review was sparked by a case report published last year in the medical journal The BMJ, in which doctors from the Ysbyty Gwynedd Hospital in Wales described a woman taking Enbrel who began to develop a schizophrenia-like disorder shortly after starting the treatment.

The middle-aged woman had no history of psychiatric illness and she recovered after being removed from Enbrel and after she was treated with an atypical antipsychotic, sulpiride, for six months. Sulpiride, sold under a variety of brand names worldwide, is not approved for use in the U.S.

Health Canada’s investigation found 25 reports of psychiatric disorders and two incidents of psychosis among those who took Enbrel in Canada, via reports submitted to the Canada Vigilance Program. However, the agency found no cases of schizophrenia. Warnings provided to users already indicate that Enbrel side effects may increase the risk of anxiety and depression.

Image Credit: |


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AT&T Data Breach Class Action Claims Telecom Giant
AT&T Data Breach Class Action Claims Telecom Giant "Disregarded" Customer Financial Safety (Posted today)

A Missouri woman is one of the latest person to file an class action claim over the AT&T data breach, after the telecom company admitted that hackers stole millions of customers' personal information and sold it on the internet.

Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL
Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL (Posted yesterday)

Plaintiffs say a federal judge should not waste time on a phased discovery plan requiring them to first prove Suboxone strips can cause tooth decay, saying the science is obvious and such a plan could delay resolution of hundreds of product liability lawsuits.